(Q48613606)

13 February 2018

title

Lamotrigine as add-on drug in children and adolescents with refractory epilepsy and mental delay: an open trial. (English)

1 reference

13 February 2018

1 reference

1 reference

G Coppola

1

1 reference

13 February 2018

A Pascotto

series ordinal

2

1 reference

13 February 2018

publication date

1 September 1997

1 reference

13 February 2018

published in

Brain and Development

1 reference

13 February 2018

volume

19

1 reference

13 February 2018

issue

6

1 reference

13 February 2018

page(s)

398-402

1 reference

13 February 2018

Pharmacological studies on lamotrigine, a novel potential antiepileptic drug: II. Neurochemical studies on the mechanism of action.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0387-7604%2897%2900046-6

7 January 2021

Double-blind crossover trial of lamotrigine (Lamictal) as add-on therapy in intractable epilepsy.

1 reference

https://api.crossref.org/works/10.1016%2FS0387-7604%2897%2900046-6

7 January 2021

Controlled trial of lamotrigine (Lamictal) for refractory partial seizures

1 reference

https://api.crossref.org/works/10.1016%2FS0387-7604%2897%2900046-6

7 January 2021

A randomised double-blind placebo-controlled crossover add-on trial of lamotrigine in patients with treatment-resistant partial seizures

1 reference

https://api.crossref.org/works/10.1016%2FS0387-7604%2897%2900046-6

7 January 2021

A randomised double-blind placebo-controlled add-on trial of lamotrigine in patients with severe epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS0387-7604%2897%2900046-6

7 January 2021

Outcomes of add-on treatment with lamotrigine in partial epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS0387-7604%2897%2900046-6

7 January 2021

Lamotrigine in treatment of 120 children with epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS0387-7604%2897%2900046-6

7 January 2021

Lamotrigine as an add-on drug in the management of Lennox-Gastaut syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0387-7604%2897%2900046-6

7 January 2021

Rechallenge with lamotrigine after initial rash

1 reference

https://api.crossref.org/works/10.1016%2FS0387-7604%2897%2900046-6

7 January 2021

Impact of lamotrigine on patients with refractory epilepsy: the Leicester experience

1 reference

https://api.crossref.org/works/10.1016%2FS0387-7604%2897%2900046-6

7 January 2021

Lamotrigine in resistant childhood epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS0387-7604%2897%2900046-6

7 January 2021

Concentration--effect and concentration--toxicity relations with lamotrigine: a prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS0387-7604%2897%2900046-6

7 January 2021

The efficacy of lamotrigine on seizure control in 34 children, adolescents and young adults with intellectual and physical disability

1 reference

https://api.crossref.org/works/10.1016%2FS0387-7604%2897%2900046-6

7 January 2021

10.1016/S0387-7604(97)00046-6

Identifiers

DOI

1 reference

13 February 2018

1 reference

13 February 2018